Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prothena Corp Public Ltd Co
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 8.33 · gapped above the open, never looked back. High/low 8.63 at 9:30 am ET, 8.33 at 3:45 pm ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Lonza Ltd ("Lonza") is our third-party manufacturer of clinical supplies of our drug candidate PRX019.”
FILING10-K0001559053-26-000008cik 0001559053
“We are dependent on BMS, and its third-party manufacturers if applicable, to manufacture clinical supplies of BMS-986446.”
FILING10-K0001559053-26-000008cik 0001559053
“We are dependent on Novo Nordisk, and its third-party manufacturers if applicable, to manufacture clinical supplies of coramitug.”
FILING10-K0001559053-26-000008cik 0001559053
“Under the terms of our collaboration with Roche, Roche is responsible for that further development, including the conduct of the Phase 3 clinical trial and any future clinical trial of that drug candidate.”
FILING10-K0001559053-26-000008cik 0001559053
“Pursuant to the Collaboration Agreement with BMS, we are eligible to receive payments for commercial and regulatory milestones and royalties on net sales of Collaboration Products.”
FILING10-K0001559053-26-000008cik 0001559053
“In July 2021, we announced that we and Novo Nordisk entered into a definitive purchase agreement under which Novo Nordisk acquired our clinical stage antibody coramitug and broader ATTR amyloidosis business.”
FILING10-K0001559053-26-000008cik 0001559053
“Pursuant to the Collaboration Agreement with Roche, we are eligible to receive payments for commercial and regulatory milestones and royalties on net sales of Collaboration Products.”
FILING10-K0001559053-26-000008cik 0001559053
“Prasinezumab - Boehringer Ingelheim Biopharmaceuticals GmbH ("BI") manufactured clinical supplies of our drug candidate prasinezumab for our completed Phase 1a single ascending dose and Phase 1b multiple ascending dose clinical trials.”
FILING10-K0001559053-26-000008cik 0001559053
“BMS, with whom we are collaborating on development of BMS-986446, is responsible for manufacturing clinical supplies for any subsequent clinical trials for BMS-986446.”
FILING10-K0001559053-26-000008cik 0001559053
“BMS-986446 (formerly PRX005) - Catalent Pharma Solutions, LLC ("Catalent Pharma") was our third-party manufacturer for drug substance and Sharp Sterile Manufacturing, LLC (formerly known as "Berkshire Sterile Manufacturing, LLC" and hereinafter referred to as "Sharp Sterile") was our third-party manufacturer for drug product for our drug candidate BMS-986446 for our Phase 1 clinical trial.”
FILING10-K0001559053-26-000008cik 0001559053
“Coramitug (formerly PRX004) - Rentschler Biopharma SE ("Rentschler") manufactured clinical supplies of our drug candidate coramitug for our completed Phase 1 clinical trial.”
FILING10-K0001559053-26-000008cik 0001559053
“BMS-986446 (formerly PRX005) - Catalent Pharma Solutions, LLC ("Catalent Pharma") was our third-party manufacturer for drug substance and Sharp Sterile Manufacturing, LLC (formerly known as "Berkshire Sterile Manufacturing, LLC" and hereinafter referred to as "Sharp Sterile") was our third-party manufacturer for drug product for our drug candidate BMS-986446 for our Phase 1 clinical trial.”
FILING10-K0001559053-26-000008cik 0001559053
Watchlist prices, news filtered to it, and its next report on your desk.
Prothena Corp Public Ltd Co has 9 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either Prothena Corp Public Ltd Co’s own annual report or the counterparty’s, and carries the sentence that discloses it.
PRTA (Prothena Corp Public Ltd Co) has 9 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BMY −0.56%, in healthcare.